1. The function of the calcium channel Orai1 in osteoclast development
- Author
-
Harry C. Blair, Robert Hooper, Paul F. Worley, Quitterie C. Larrouture, Scott Gross, Irina L. Tourkova, Jonathan Soboloff, John B. Barnett, Lisa J. Robinson, Elsie Samakai, and Michelle R. Witt
- Subjects
0301 basic medicine ,musculoskeletal diseases ,Male ,Myeloid ,ORAI1 Protein ,Osteoclasts ,Biochemistry ,Peripheral blood mononuclear cell ,Bone resorption ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Multinucleate ,Osteoclast ,Genetics ,Null cell ,medicine ,Animals ,Molecular Biology ,Tartrate-resistant acid phosphatase ,Mice, Knockout ,Bone Development ,Chemistry ,Tartrate-Resistant Acid Phosphatase ,Cell Differentiation ,Molecular biology ,Resorption ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Calcium ,Female ,030217 neurology & neurosurgery ,Biotechnology - Abstract
To determine the intrinsic role of Orai1 in osteoclast development, Orai1-floxed mice were bred with LysMcre mice to delete Orai1 from the myeloid lineage. PCR, in situ labelling and Western analysis showed Orai1 deletion in myeloid-lineage cells, including osteoclasts, as expected. Surprisingly, bone resorption was maintained in vivo, despite loss of multinucleated osteoclasts; instead, a large number of mononuclear cells bearing tartrate resistant acid phosphatase were observed on cell surfaces. An in vitro resorption assay confirmed that RANKL-treated Orai1 null cells, also TRAP-positive but mononuclear, degraded matrix, albeit at a reduced rate compared to wild type osteoclasts. This shows that mononuclear osteoclasts can degrade bone, albeit less efficiently. Further unexpected findings included that Orai1(fl/fl)-LysMcre vertebrae showed slightly reduced bone density in 16-week-old mice, despite Orai1 deletion only in myeloid cells; however, this mild difference resolved with age. In summary, in vitro analysis showed a severe defect in osteoclast multinucleation in Orai1 negative mononuclear cells, consistent with prior studies using less targeted strategies, but with evidence of resorption in vivo and unexpected secondary effects on bone formation leaving bone mass largely unaffected.
- Published
- 2021